2509 — Qyuns Therapeutics Co Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.34bn
- HK$3.30bn
- CNY158.79m
Annual cashflow statement for Qyuns Therapeutics Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -427 | -312 | -521 | -350 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 259 | 29.8 | 138 | 82.9 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 19.6 | 26.9 | 50 | 48.1 |
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Other Assets | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -123 | -225 | -301 | -186 |
| Capital Expenditures | -58.9 | -22.8 | -7.95 | -1.76 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -188 | 17.1 | 251 | -23.5 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -247 | -5.7 | 243 | -25.2 |
| Financing Cash Flow Items | 284 | -15.9 | -15.2 | -18.3 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 281 | 211 | 61.2 | 352 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -91.2 | -4.96 | 3.21 | 144 |